BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25064192)

  • 1. Appetite stimulants for people with cystic fibrosis.
    Chinuck R; Dewar J; Baldwin DR; Hendron E
    Cochrane Database Syst Rev; 2014 Jul; (7):CD008190. PubMed ID: 25064192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appetite stimulants for people with cystic fibrosis.
    McTavish D; Thornton J
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD008190. PubMed ID: 36149378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appetite stimulants in cystic fibrosis: a systematic review.
    Chinuck RS; Fortnum H; Baldwin DR
    J Hum Nutr Diet; 2007 Dec; 20(6):526-37. PubMed ID: 18001374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acid supplementation for cystic fibrosis.
    Watson H; Stackhouse C
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics for people with cystic fibrosis.
    Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatments for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
    Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
    Southern KW; Patel S; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting inhaled bronchodilators for cystic fibrosis.
    Smith S; Edwards CT
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD012102. PubMed ID: 29253920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
    Thaker V; Carter B; Putman M
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD008901. PubMed ID: 30557452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megestrol acetate for treatment of anorexia-cachexia syndrome.
    Ruiz Garcia V; López-Briz E; Carbonell Sanchis R; Gonzalvez Perales JL; Bort-Marti S
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD004310. PubMed ID: 23543530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee TW; Southern KW; Perry LA; Penny-Dimri JC; Aslam AA
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005599. PubMed ID: 27314455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant supplementation for lung disease in cystic fibrosis.
    Ciofu O; Lykkesfeldt J
    Cochrane Database Syst Rev; 2014 Aug; (8):CD007020. PubMed ID: 25102015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral calorie supplements for cystic fibrosis.
    Smyth RL; Rayner O
    Cochrane Database Syst Rev; 2017 May; 5(5):CD000406. PubMed ID: 28470972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis.
    Leśniak W; Bała M; Jaeschke R; Krzakowski M
    Pol Arch Med Wewn; 2008 Nov; 118(11):636-44. PubMed ID: 19140567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megestrol acetate for the treatment of anorexia-cachexia syndrome.
    Berenstein EG; Ortiz Z
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.
    Palser S; Smith S; Nash EF; Agarwal A; Smyth AR
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012300. PubMed ID: 31845758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E supplementation in people with cystic fibrosis.
    Okebukola PO; Kansra S; Barrett J
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD009422. PubMed ID: 28262916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E supplementation in people with cystic fibrosis.
    Okebukola PO; Kansra S; Barrett J
    Cochrane Database Syst Rev; 2014 Dec; (12):CD009422. PubMed ID: 25489958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E supplementation in people with cystic fibrosis.
    Okebukola PO; Kansra S; Barrett J
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD009422. PubMed ID: 32892350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.